Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Submitted by
admin
on April 4, 2018 - 10:12pm
Source:
Biopharma Dive
News Tags:
Amgen
Repatha
Headline:
Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Do Not Allow Advertisers to Use My Personal information
